C4 CRE investigators collaborate with colleagues in national and international committees and working groups, including:
- Asia Oceania Research Organisation on Genital Infections on Genital Infections and Neoplasia (AOGIN)
- Australian National Cervical Screening Program Quality and Safety Monitoring Committee
- Australian NPAAC Cervical Screening Drafting Committee
- Australian Regional Immunisation Alliance
- Cancer Research Advisory Committee, Cancer Institute NSW
- Cancer Screening Committee, Cancer Council Australia
- Cervical cancer expert reference group for National Optimal Care Pathway. Cancer Council Victoria
- Cervical Drafting Committee to undertake a review of the National Pathology Accreditation Advisory Committee document; Requirements for Laboratories Reporting Tests for the National Cervical Screening Program. The Department of Health
- Epidemiology and Research in Cancer Biology, Groups. Instituto Nacional de Cancerologia, Bogota, Colombia. Prevention and Implementation Group
- European Research Organization on Genital Infection and Neoplasia (EUROGIN)
- Evaluation and Research Working Group for the Victorian Cancer Screening Framework (Department of Health, Victoria)
- Expert Medical Panel at The Australian Cervical Cancer Foundation
- Healthcare Services Advisory Committee, Cancer Council Australia
- HPV Sub-committee of the New Zealand National Cervical Screening Program Technical Reference Group, Ministry of Health, New Zealand
- HPV Surveillance Working Group to update the HPV Surveillance Plan – an integrated approach to monitoring the impact of HPV vaccination in Australia. The Department of Health
- HPV Test Characteristics Expert Panel and Consultant to Cancer Care Ontario
- HPV Testing for Primary Screening Project Technical Reference Group Ministry of Health, New Zealand
- Improving Cancer Outcomes for Aboriginal Communities Working group
- International Agency for Research on Cancer (IARC) Handbooks of Cancer Prevention, Advisory Group to Recommend an Update to the Working Procedures
- International Agency for Research on Cancer (IARC) Working Group for Handbook 18 on Cervical Screening
- International Papillomavirus Society
- Medical & Scientific Committee of the Cancer Council of Victoria
- National Centre for Immunisation Research and Surveillance Expert Advisory Committee for the evaluation of the National HPV Vaccination Program
- National Cervical Screening Program Clinical Expert Panel
- National Cervical Screening Program Self-Collection Expert Advisory Group, Department of Health
- National Cervical Screening Program Self-Collection Working Group
- National Health and Medical Research Council Grant Review Panels
- National Pathology Accreditation Advisory Committee Self-Collect Validation Working Group
- Ontario Cervical Screening Program Screening and Colposcopy Recommendations, Ontario Health
- Pacific Friends of Global Health Advisory Board, University of Melbourne
- PATH Single Dose HPV Vaccine Evaluation Consortium
- Positive Life NSW’s HPV Working Group
- Project Steering Committee, Australian Government – Cancer Australia: Using data to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander women
- Protocol Advisory Sub-Committee (PASC), a standing sub-committee of the Medical Services Advisory Committee (MSAC)
- Public Health Committee, Cancer Council Australia
- Quality and Safety Monitoring Committee’s Quality Framework Working Group, National Cervical Screening Program
- Research and Data Advisory Group, Cancer Australia
- Steering Committee, Cancer Council Victoria’s Eliminate Cervical Cancer Fund
- Under-screened Program Steering Group (Department of Health, Victoria)
- Victorian Cancer Agency Mid-Career Research Fellowship Evaluation Panel
- Victorian Cancer Register Strategic Advisory Group
- Victorian Renewal Advisory Committee
- WHO Cervical Cancer Elimination Data Monitoring Group
- WHO CIN Screen and Treat Update Guideline Development Group
- WHO Director-General’s Expert Advisory Group on the Elimination of Cervical Cancer Working Party – Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding, Cancer Council Australia